Theoretical Based Case Management Intervention for Dementia Family Caregivers
NCT ID: NCT02747745
Last Updated: 2016-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
152 participants
INTERVENTIONAL
2016-01-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Care Model for Elderly Hip-fractured Persons With Cognitive Impairment and Their Family Caregivers
NCT03894709
A Home-based Training Program for Elderly Patients With Dementia
NCT02667951
Establishment of Core Competence and Training Model for Dementia Case Management
NCT05151185
Case Manager Approach in Dementia Care From a Caregiver Perspective
NCT04845789
Powerful Tools for Caregivers of Dementia Patients
NCT02697721
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To increase the feasibility of this project, the inclusion criteria of PWDs are made to reflect the recruiting site reality, including: (1) age being older than 60 years old; (2) having a primary FCG or a secondary FCG who can provides sufficient information and assistant for the PWD; co-residence is not required; (3) PWDs are those with cognitive impairment confirmed by the primary or secondary FCG or participating neurologists. The exclusion criteria of PWDs include: (1) acute illnesses, impaired sensory symptoms (hearing loss and severe visual problems); (2) acute agitation which requires emergency treatment; (3) chronic alcohol abuse or use of drugs which possibly affect central nervous system functions; (4) presence of major psychiatric disorders within the last 2 years; (5) neurological or systemic illness (e.g. delirium, hypoxia, or unstable thyroid dysfunction); (6) no primary FCG or secondary FCG.
Investigator will screen for FCGs who report and meet the criteria of moderate levels of severity in the following risk areas (Table 1): depressive symptoms, burden, distress to problematic behaviors of PWDs and healthy behaviors. The definition of primary FCG include: (1) age 18 years old or greater; (2) at least providing the most assistance (4 hours a day) to their relatives with dementia for the past three months or those who conduct secondary care to their relatives, meaning that these FCGs supervise the hired care assistants or foreign helpers who actually take care of the patients; co-residency is not required for family caregivers. Exclusion criteria of family caregivers include: (1) documented cognitive or mental disorder, such as severe memory problems or major affective disorders; (2) hearing or visual impairments which are not properly corrected; (3) prescribed drugs known to impair or enhance attention, e.g., antidepressants, barbiturates, or other depressants, amphetamines; (4) insufficient command of Mandarin, Taiwanese; (5) participation in other interventions which may contaminate the results of this study.
In previous project, the satisfactory level of our case management training course was high. All the trainees had the highest regard toward the professional quality of the content and the instructors (Chiu et al, 2013). One of the case managers served as research assistant in the previous project and will continue to work with us as interventionist upon funded. Investigator will conduct a three-year RCT involving repeated measures at four time points: baseline screening (T0), 4th month (the end of the intervention, T1), 6th month (post-treatment follow up, T2), 12th month (T3).
Randomization Randomization takes place after baseline assessment. An external independent person establishes the random order using random number tables.
CM Intervention Protocol The 4-month CM intervention on FCGs of PWDs involves 2 home visits, 2 phone calls from the case manager to the dyads, and receiving telephone calls from FCGs during the working hours (Monday through Friday, 9-5). The case manager will target the prioritized risk from the 4 risk areas of FCG problems: depressive symptoms, burden, distress to problematic behaviors of PWDs, and healthy behaviors (Table 1). The intervention mainly consists of 1. needs assessment and nursing education on home environment modification and safety, behavioral management and communication skills(Belle et al., 2006); 2. home-based cognitive stimulation on PWD with simple mathematical practice (Cheng et al., 2013), patient preferred leisure activities (Chiu et al., 2015) and reminiscence by old time photos, stories and toys (Chiu et al., 2013); 3. brief consultation on 4 risk areas related to FCG stress (Belle et al., 2006) and 4. case management to refer the dyads to the hospital-based dementia centers and community resources (Chien et al., 2010). The case manager will assess the recruited dyads at the beginning of the intervention (T0), develop a tailored care plan based on the prioritized risk area of the FCGs and conduct the first home visit in the 1st month to build up a partnership with FCGs, discuss the care plan with the FCGs (and PWDs if possible). Each risk area of each FCG will be dealt with CM components such as education, brief counseling, problem solving and evidence based strategies derived from the Pearlin's theoretical principles. The case manager will teach the FCGs how to implement the home-based cognitive stimulation and cognitive training for PWDs and provide them the daily log for recording these activities and any leisure-time physical activities as well as medical cost. There will be two telephone calls in the 2nd and 3rd months to reinforce the dyads about the taught strategies, collect the log data and remind them the date of the next home visit (4th month). If the problems in each risk area persist until the first phone call, the case manager will discuss this case in a multidisciplinary conference in the participating dementia centers with nurses, social workers, clinical psychologists and neurologists. Then a revised care plan will be developed and additional home visit will be conducted in the 3rd month. If it is necessary, the case manager will refer the dyads to the hospital-based dementia centers, memory clinics or governmental resources. The frequent contacts are to ensure the CM strategies can reflect the changing needs of the FCGs. The definition of compliance is 80% of CM strategies completed by the dyads. The outcome data will be collected after the recruitment in the 4th month (T1), 6th month (T2) and 12th moth (T3) either by home visits or dementia center or memory clinic visits.
To ensure the quality of medical care, both group participants will be followed up at three monthly intervals in the dementia centers. PWDs of the experimental and control groups will receive standard medical treatment as clinically indicated.
For the control group, after the initial assessment, the case manager will give the dyads written information about dementia and its progress as well as home safety during the first home visit. Then case manager will make 2 phone calls in the 2nd and 3rt months for social interactions with the control group and collect the cost data. These phone calls do not involve in active education, consultation or cognitive stimulation and training. The control dyads will remain their usual care, i.e., visiting their primary care physicians or special neurologists for treatments or related consultation as well as education. The participating physicians will be unaware of the dyads allocation to either intervention or control condition. The dyads in the control group have no access to most of the structured and tailored activities. The outcome data will be collected at the 4th month (T1), 6th month (T2) and 12th month (T3)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Group receive no intervention
No interventions assigned to this group
Interventional Group
Four risk areas reflecting the great needs of FCGs of PWDs: depressive symptoms, burden, distress to problematic behaviors of PWDs and healthy behaviors.
Four risk areas reflecting the great needs of FCGs of PWDs
The intervention involves home visits \& phone calls from the case manager to the dyads, and receiving telephone calls from FCGs. The case manager will target the prioritized risk from the 4 risk areas of FCG problems and healthy behaviors. The intervention mainly consists of needs assessment and nursing education on home environment modification and safety, behavioral management and communication skills; home-based cognitive stimulation on PWD with simple mathematical practice, patient preferred leisure activities and reminiscence by old time photos, stories and toys; brief consultation on 4 risk areas related to FCG stress; and case management to refer the dyads to the hospital-based dementia centers and community resources.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Four risk areas reflecting the great needs of FCGs of PWDs
The intervention involves home visits \& phone calls from the case manager to the dyads, and receiving telephone calls from FCGs. The case manager will target the prioritized risk from the 4 risk areas of FCG problems and healthy behaviors. The intervention mainly consists of needs assessment and nursing education on home environment modification and safety, behavioral management and communication skills; home-based cognitive stimulation on PWD with simple mathematical practice, patient preferred leisure activities and reminiscence by old time photos, stories and toys; brief consultation on 4 risk areas related to FCG stress; and case management to refer the dyads to the hospital-based dementia centers and community resources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. having a primary FCG or a secondary FCG who can provides sufficient information and assistant for the PWD; co-residence is not required;
3. PWDs are those with cognitive impairment confirmed by the primary or secondary FCG or participating neurologists
Exclusion Criteria
2. acute agitation which requires emergency treatment;
3. chronic alcohol abuse or use of drugs which possibly affect central nervous system functions;
4. presence of major psychiatric disorders within the last 2 years;
5. neurological or systemic illness (e.g. delirium, hypoxia, or unstable thyroid dysfunction);
6. no primary FCG or secondary FCG.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chang Gung Memorial Hospital
OTHER
Chang Gung University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yi-Chien, Chiu
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yi-Chen Chiu, PhD.
Role: PRINCIPAL_INVESTIGATOR
Chang Gung University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Catholic Mercy Hospital
Hukou, Hsinchu, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMRPD1F0051
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
CMRPD1F0051
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.